| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |